Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
2055041-02-4
2055024-44-5
175885-18-4 | Biotin-peg2-nh-boc | AA019E70 | MFCD30527392
2112738-09-5 | Mal-peg4-val-cit-pab-pnp | AA019EBE | MFCD30828694
2183473-23-4 | BDP R6G azide | AA019EFQ | MFCD31580117
1823794-46-2 | tert-Butyl 4-(1-benzyl-1H-imidazol-2-yl)-4-hydroxypiperidine-1-carboxylate | AA019EIU | MFCD27997367
1312784-54-5 | 1,2,2-Trimethylpiperazine hydrochloride | AA019EM8 | MFCD09864551
128638-55-1 | 1,3-dimethoxy-5-[(E)-2-nitroprop-1-enyl]benzene | AA019EPE | MFCD00052911
924909-16-0 | 1-(4-Methoxybenzyl)-1H-pyrazolo[3,4-b]pyridin-4-ol | AA019ESH | MFCD20485436
869557-79-9 | Ethyl2-oxo-2-(1H-pyrazol-4-yl)acetate | AA019EW0 | MFCD16621373
914606-88-5 | N-[4-(Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]benzenesulfonamide | AA019EZ1 | MFCD22494428
73384-59-5 | Ceftriaxone sodium | AA019FSK | MFCD00865013